BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23934451)

  • 1. Loss of function of Slc20a2 associated with familial idiopathic Basal Ganglia calcification in humans causes brain calcifications in mice.
    Jensen N; Schrøder HD; Hejbøl EK; Füchtbauer EM; de Oliveira JR; Pedersen L
    J Mol Neurosci; 2013 Nov; 51(3):994-9. PubMed ID: 23934451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of gene expression pattern and neuroanatomical correlates for SLC20A2 (PiT-2) shows a molecular network with potential impact in idiopathic basal ganglia calcification ("Fahr's disease").
    da Silva RJ; Pereira IC; Oliveira JR
    J Mol Neurosci; 2013 Jun; 50(2):280-3. PubMed ID: 23576097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene.
    Sekine SI; Kondo T; Murakami N; Imamura K; Enami T; Shibukawa R; Tsukita K; Funayama M; Inden M; Kurita H; Hozumi I; Inoue H
    Stem Cell Res; 2017 Oct; 24():40-43. PubMed ID: 29034894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel SLC20A2 mutations identified in southern Chinese patients with idiopathic basal ganglia calcification.
    Chen WJ; Yao XP; Zhang QJ; Ni W; He J; Li HF; Liu XY; Zhao GX; Murong SX; Wang N; Wu ZY
    Gene; 2013 Oct; 529(1):159-62. PubMed ID: 23939468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and therapeutic potential of sodium-dependent phosphate cotransporters in relation to idiopathic basal ganglia calcification.
    Inden M; Kurita H; Hozumi I
    J Pharmacol Sci; 2022 Jan; 148(1):152-155. PubMed ID: 34924120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial idiopathic basal ganglia calcification: Histopathologic features of an autopsied patient with an SLC20A2 mutation.
    Kimura T; Miura T; Aoki K; Saito S; Hondo H; Konno T; Uchiyama A; Ikeuchi T; Takahashi H; Kakita A
    Neuropathology; 2016 Aug; 36(4):365-71. PubMed ID: 26635128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between a novel mutation in SLC20A2 and familial idiopathic basal ganglia calcification.
    Zhang Y; Guo X; Wu A
    PLoS One; 2013; 8(2):e57060. PubMed ID: 23437308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Brain Calcification Causal PiT2 Transport-Knockout Variants can Exert Dominant Negative Effects on Wild-Type PiT2 Transport Function in Mammalian Cells.
    Larsen FT; Jensen N; Autzen JK; Kongsfelt IB; Pedersen L
    J Mol Neurosci; 2017 Feb; 61(2):215-220. PubMed ID: 27943094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC20A2 Deficiency in Mice Leads to Elevated Phosphate Levels in Cerbrospinal Fluid and Glymphatic Pathway-Associated Arteriolar Calcification, and Recapitulates Human Idiopathic Basal Ganglia Calcification.
    Wallingford MC; Chia JJ; Leaf EM; Borgeia S; Chavkin NW; Sawangmake C; Marro K; Cox TC; Speer MY; Giachelli CM
    Brain Pathol; 2017 Jan; 27(1):64-76. PubMed ID: 26822507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fahr's disease linked to a novel SLC20A2 gene mutation manifesting with dynamic aphasia.
    Brighina L; Saracchi E; Ferri F; Gagliardi M; Tarantino P; Morzenti S; Musarra M; Patassini M; Annesi G; Ferrarese C
    Neurodegener Dis; 2014; 14(3):133-8. PubMed ID: 25348593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis.
    Wang C; Li Y; Shi L; Ren J; Patti M; Wang T; de Oliveira JR; Sobrido MJ; Quintáns B; Baquero M; Cui X; Zhang XY; Wang L; Xu H; Wang J; Yao J; Dai X; Liu J; Zhang L; Ma H; Gao Y; Ma X; Feng S; Liu M; Wang QK; Forster IC; Zhang X; Liu JY
    Nat Genet; 2012 Feb; 44(3):254-6. PubMed ID: 22327515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification.
    Hsu SC; Sears RL; Lemos RR; Quintáns B; Huang A; Spiteri E; Nevarez L; Mamah C; Zatz M; Pierce KD; Fullerton JM; Adair JC; Berner JE; Bower M; Brodaty H; Carmona O; Dobricić V; Fogel BL; García-Estevez D; Goldman J; Goudreau JL; Hopfer S; Janković M; Jaumà S; Jen JC; Kirdlarp S; Klepper J; Kostić V; Lang AE; Linglart A; Maisenbacher MK; Manyam BV; Mazzoni P; Miedzybrodzka Z; Mitarnun W; Mitchell PB; Mueller J; Novaković I; Paucar M; Paulson H; Simpson SA; Svenningsson P; Tuite P; Vitek J; Wetchaphanphesat S; Williams C; Yang M; Schofield PR; de Oliveira JR; Sobrido MJ; Geschwind DH; Coppola G
    Neurogenetics; 2013 Feb; 14(1):11-22. PubMed ID: 23334463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slc20a2 is critical for maintaining a physiologic inorganic phosphate level in cerebrospinal fluid.
    Jensen N; Autzen JK; Pedersen L
    Neurogenetics; 2016 Apr; 17(2):125-30. PubMed ID: 26660102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial reduced Pi transport function of PiT-2 might not be sufficient to induce brain calcification of idiopathic basal ganglia calcification.
    Nishii K; Shimogawa R; Kurita H; Inden M; Kobayashi M; Toyoshima I; Taguchi Y; Ueda A; Tamune H; Hozumi I
    Sci Rep; 2019 Nov; 9(1):17288. PubMed ID: 31754123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification.
    Nicolas G; Pottier C; Charbonnier C; Guyant-Maréchal L; Le Ber I; Pariente J; Labauge P; Ayrignac X; Defebvre L; Maltête D; Martinaud O; Lefaucheur R; Guillin O; Wallon D; Chaumette B; Rondepierre P; Derache N; Fromager G; Schaeffer S; Krystkowiak P; Verny C; Jurici S; Sauvée M; Vérin M; Lebouvier T; Rouaud O; Thauvin-Robinet C; Rousseau S; Rovelet-Lecrux A; Frebourg T; Campion D; Hannequin D;
    Brain; 2013 Nov; 136(Pt 11):3395-407. PubMed ID: 24065723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting a new mutation at the SLC20A2 gene in familial idiopathic basal ganglia calcification.
    Lemos RR; Oliveira MF; Oliveira JRM
    Eur J Neurol; 2013 Mar; 20(3):e43-e44. PubMed ID: 23406454
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of SLC20A2 mutations that cause idiopathic basal ganglia calcification in Japan.
    Yamada M; Tanaka M; Takagi M; Kobayashi S; Taguchi Y; Takashima S; Tanaka K; Touge T; Hatsuta H; Murayama S; Hayashi Y; Kaneko M; Ishiura H; Mitsui J; Atsuta N; Sobue G; Shimozawa N; Inuzuka T; Tsuji S; Hozumi I
    Neurology; 2014 Feb; 82(8):705-12. PubMed ID: 24463626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall mutational spectrum of SLC20A2, PDGFB and PDGFRB in idiopathic basal ganglia calcification.
    Nicolas G; Richard AC; Pottier C; Verny C; Durif F; Roze E; Favrole P; Rudolf G; Anheim M; Tranchant C; Frebourg T; Campion D; Hannequin D
    Neurogenetics; 2014 Aug; 15(3):215-6. PubMed ID: 24770784
    [No Abstract]   [Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cell line (ZZUi0012-A) from a patient with Fahr's disease caused by a novel mutation in SLC20A2 gene.
    Zhang Q; Li Z; Sun H; Zhang S; Zhang J; Wang Y; Fang H; Xu Y
    Stem Cell Res; 2019 Mar; 35():101395. PubMed ID: 30776674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inorganic phosphorus (Pi) in CSF is a biomarker for SLC20A2-associated idiopathic basal ganglia calcification (IBGC1).
    Hozumi I; Kurita H; Ozawa K; Furuta N; Inden M; Sekine SI; Yamada M; Hayashi Y; Kimura A; Inuzuka T; Seishima M
    J Neurol Sci; 2018 May; 388():150-154. PubMed ID: 29627011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.